China Regenerative Medicine International Balance Sheet Health
Financial Health criteria checks 4/6
China Regenerative Medicine International has a total shareholder equity of HK$111.6M and total debt of HK$51.4M, which brings its debt-to-equity ratio to 46.1%. Its total assets and total liabilities are HK$283.0M and HK$171.4M respectively. China Regenerative Medicine International's EBIT is HK$21.0M making its interest coverage ratio 18.4. It has cash and short-term investments of HK$1.4M.
Key information
46.1%
Debt to equity ratio
HK$51.44m
Debt
Interest coverage ratio | 18.4x |
Cash | HK$1.42m |
Equity | HK$111.64m |
Total liabilities | HK$171.36m |
Total assets | HK$283.00m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 8592's short term assets (HK$260.1M) exceed its short term liabilities (HK$162.6M).
Long Term Liabilities: 8592's short term assets (HK$260.1M) exceed its long term liabilities (HK$8.7M).
Debt to Equity History and Analysis
Debt Level: 8592's net debt to equity ratio (44.8%) is considered high.
Reducing Debt: 8592's debt to equity ratio has reduced from 46.6% to 46.1% over the past 5 years.
Debt Coverage: 8592's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: 8592's interest payments on its debt are well covered by EBIT (18.4x coverage).